You are here
149 BIO LLC
Company Information
Information
UEI: PUXSSH1GHNF7
# of Employees: 2
Ownership Information
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Integrin-Targeted Novel Oral Therapeutics for Lupus Nephritis
Amount: $306,500.00Project SummaryLupus nephritis (LN) remains the strongest predictor of morbidity and mortality for people with Systemic Lupus Erythematosus (SLE), an autoimmune disease disproportionately affecting wo ...
SBIRPhase I2023Department of Health and Human Services National Institutes of Health